Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.

Source:http://linkedlifedata.com/resource/pubmed/id/15767106

Download in:

View as

General Info

PMID
15767106